Consensus Fresenius Medical Care AG Deutsche Boerse AG

Equities

FME

DE0005785802

Market Closed - Deutsche Boerse AG Other stock markets 03:30:56 2024-04-26 pm EDT			5-day change	1st Jan Change
37.4 ^EUR	-2.48%		+1.99%	-1.37%

Apr. 26	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	ZD
Apr. 24	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT

Evolution of the average Target Price on Fresenius Medical Care AG

Price target over the last 5 years

History of analyst recommendation changes

01fa868868cdb3e299e0.81BuJD1f53RffhIG1OHf3Zs9M78cJWNocQyFumvKpDE.njoiZnIpsTMOMiZjlYbqkqkMZodNawEQIlvGyliJ61q_BxtFdz2zGy80Kg~e4773fd6e2742142a273db1e278033e0

Analyst Recommendations on Fresenius Medical Care AG

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	Apr. 26	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : DZ Bank sticks Neutral	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from Jefferies	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays gives a Neutral rating	Apr. 22	ZD
Berenberg rates FMC at 'Buy' - Target 47 euros	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Berenberg	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reiterates its Sell rating	Apr. 19	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan gives a Sell rating	Apr. 04	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reaffirms its Neutral rating	Mar. 05	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg keeps its Buy rating	Mar. 05	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from DZ Bank	Mar. 04	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Bernstein reiterates its Neutral rating	Feb. 27	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs gives a Buy rating	Feb. 23	ZD
Berenberg: Fresenius Medical Care to Experience Solid Growth in FY24 as Demand Recovers	Feb. 22	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg keeps its Buy rating	Feb. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating	Feb. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan	Feb. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from UBS	Feb. 21	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating	Feb. 21	ZD
FRESENIUS MEDICAL CARE : Barebone 2023 profitability is a much lower starting point	Feb. 21
FRESENIUS MEDICAL CARE : Things are on track, but not all is good	Feb. 20
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Warburg Research	Feb. 20	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

37.42 EUR

Average target price

39.01 EUR

Spread / Average Target

+4.24%

High Price Target

58.5 EUR

Spread / Highest target

+56.33%

Low Price Target

26 EUR

Spread / Lowest Target

-30.52%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Fresenius Medical Care AG

JEFFERIES	James Vane-Tempest
WARBURG RESEARCH	Christian Ehmann
DEUTSCHE BANK RESEARCH	Falko Friedrichs
GOLDMAN SACHS	Richard Felton
DZ BANK	Sven Kürten
BARCLAYS	Hassan Al-Wakeel
BERENBERG	Victoria Lambert
JPMORGAN	David Adlington
BERNSTEIN RESEARCH	Lisa Bedell Clive
alphavalue	Martin Schnee
UBS	Graham Doyle
MORGAN STANLEY	Robert Davies
HSBC
CREDIT SUISSE	Christoph Gretler
Truist Securities
Jefferies & Co.
DEUTSCHE BANK	Falko Friedrichs
Oddo BHF
STIFEL	Daniel Grigat
KEPLER CHEUVREUX	Oliver Reinberg
RBC Capital Markets
NORDLB	Holger Fechner
INDEPENDENT RESEARCH	Tobias Gottschalt
RBC	Frank Morgan
BANK OF AMERICA (BOFA)

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar